Atlas Trials

Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)

Clinical trial NCT07714616 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07714616
Sponsor
Eurofarma Laboratorios S.A.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Contraception
Start date
2027-05-31
Primary completion
2029-05-31
Enrollment
1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.